Background and Key Drivers Leading to Clinical Immunogenicity Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
Improving on Rituximab – Selecting CD20 mAb for the Future Professor Mark Cragg, Southampton University, speaking at BioProcessing, Biologics & Biotherapeutics Congress Europe 2011.
Antibody Fragments - New Approaches for Production Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
New Tools for Flexible Manufacturing of Monoclonal Antibodies In this webinar, Dr. Jagschies discusses new tools for flexible manufacturing.
Progression of HCV Infection to Hepatocellular Carcinoma Radoslav Goldman, Associate Professor, Georgetown University, speaking at European Biomarkers Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
Sensitive and High Throughput Multiplexed Immunoassays for Biomarker Discovery in Biobanked Samples Using Proximity Ligation Assays and qPCR Simon Fredriksson, Chief Scientific Officer, Olink Bioscience, speaking at European Biomarkers Summit 2009
Immunoprofiling of Cancer-Specific Antibodies on Protein Microarrays of Novel Tumor Antigens Michael Tainsky, Professor, Wayne State University, speaking at Microarray World Congress 2009